Quipt Home Medical (QIPT) EBITDA Margin (2023 - 2025)
Quipt Home Medical (QIPT) has disclosed EBITDA Margin for 3 consecutive years, with 24.29% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin fell 248.0% year-over-year to 24.29%, compared with a TTM value of 14.61% through Dec 2025, down 1617.0%, and an annual FY2025 reading of 14.51%, down 1161.0% over the prior year.
- EBITDA Margin was 24.29% for Q4 2025 at Quipt Home Medical, up from 9.63% in the prior quarter.
- Across five years, EBITDA Margin topped out at 27.76% in Q1 2024 and bottomed at 27.46% in Q3 2024.
- Average EBITDA Margin over 3 years is 13.16%, with a median of 15.39% recorded in 2025.
- Peak annual rise in EBITDA Margin hit 3709bps in 2025, while the deepest fall reached -1237bps in 2025.
- Year by year, EBITDA Margin stood at 17.13% in 2023, then surged by 56bps to 26.77% in 2024, then fell by -9bps to 24.29% in 2025.
- Business Quant data shows EBITDA Margin for QIPT at 24.29% in Q4 2025, 9.63% in Q3 2025, and 13.61% in Q2 2025.